[2] T. Vanden Boom, J.E. Cronan Jr., Annu. Rev. Microbiol. 43 (1989) 317–343.
[3] A. Chopra, G.K. Khuller, Crit. Rev. Microbiol. 11 (1984) 209–271.
[4] A.A. Spector, M.A. Yorek, J. Lipid Res. 26 (1985) 1015–1035.
[5] G. Garab, K. Lohner, P. Laggner, T. Farkas, Trends Plant Sci. 5 (2000) 489–494.
[6] Y. Deng, S.D. Kohlwein, C.A. Mannella, Protoplasma 219 (2002) 160–167.
[7] S. Morein, A. Andersson, L. Rilfors, G. Lindblom, J. Biol. Chem. 271 (1996) 6801–6809.
[8] J.E. Rothman, J. Lenard, Science 195 (1977) 743–753.
[9] E.M. Bevers, P. Comfurius, D.W. Dekkers, M. Harmsma, and R.F. Zwaal, Lupus 7 Suppl 2
(1998) S126–S131.
[10] R.F. Zwaal, A.J. Schroit, Blood 89 (1997) 1121–1132.
[11] E. Prenner, G. Honsek, D. Honig, D. Mobius, K. Lohner, Chem. Phys. Lipids 145 (2007) 106–118.
[12] M. Seigneuret, P.F. Devaux, Proc. Natl. Acad. Sci. USA 81 (1984) 3751–3755.
[13] M.A. Kol, A.I. de Kroon, J.A. Killian, B. de Kruijff, Biochemistry 43 (2004) 2673–2681.
[14] V.A. Fadok, D.R. Voelker, P.A. Campbell, J.J. Cohen, D.L. Bratton, P.M. Henson, J. Immunol.
148 (1992) 2207–2216.
[15] S.J. Martin, C.P. Reutelingsperger, A.J. McGahon, J.A. Rader, R.C. van Schie, D.M. LaFace,
D.R. Green, J. Exp. Med. 182 (1995) 1545–1556.
[16] R.F. Zwaal, P. Comfurius, E.M. Bevers, Cell. Mol. Life Sci. 62 (2005) 971–988.
[17] S.M. Hammond, P.A. Lambert, A.N. Rycroft, The Bacterial Cell Surface, Croom Helm,
London, 1984.
[18] S.G. Wilkinson, Gram-negative bacteria, in: C. Ratledge, S.G. Wilkinson (Eds.), Microbial
Lipids, Academic Press, London, 1988, pp. 299–488.
[19] A. Aspedon, E.A. Groisman, Antimicrobial peptide resistance mechanisms in bacteria, in: K.
Lohner, (Ed.), Development of Novel Antimicrobial Agents: Emerging Strategies, Horizon
Scientific Press, Norfolk, UK, 2001, pp. 31–44.
[20] R.P. Huijbregts, A.I. de Kroon, B. de Kruijff, Biochim. Biophys. Acta 1469 (2000) 43–61.
[21] C.P. Sparrow, C.R. Raetz, J. Biol. Chem. 260 (1985) 12084–12091.
[22] R.T. Ambron, R.A. Pieringer, Phospholipids in micro-organisms, in: G.B. Ansell, J.N. Hawthorne,
R.M.C. Dawson (Eds.), Form and Function of Phospholipids, Elsevier, Amsterdam, 1973,
pp. 289–331.
[23] W.M. O’Leary, S.G. Wilkinson, Gram-positive bacteria, in: C. Ratledge, S.G. Wilkinson
(Eds.), Microbial Lipids, Academic Press, London, 1988, pp. 117–201.
[24] A. Peschel, M. Otto, R.W. Jack, H. Kalbacher, G. Jung, F. Gotz, J. Biol. Chem. 274 (1999)
8405–8410.
[25] S.D. Shukla, C. Green, J.M. Turner, Biochem. J. 188 (1980) 131–135.
[26] L.I. Barsukov, V.I. Kulikov, L.D. Bergelson, Biochem. Biophys. Res. Commun. 71 (1976)
704–711.
[27] D.G. Bishop, J.A. Op den Kamp, L.L. van Deenen, Eur. J. Biochem. 80 (1977) 381–391.
[28] J.E. Rothman, E.P. Kennedy, J. Mol. Biol. 110 (1977) 603–618.
[29] S.E. Blondelle, K. Lohner, Biopolymers 55 (2000) 74–87.
[30] K. Lohner (Ed.), Development of Novel Antimicrobial Agents: Emerging Strategies, Horizon
Scientific Press, Wymondham, Norfolk, UK, 2001.
[31] M.A. Baker, W.L. Maloy, M. Zasloff, L.S. Jacob, Cancer Res. 53 (1993) 3052–3057.
[32] T. Ganz, R.I. Lehrer, Curr. Opin. Immunol. 10 (1998) 41–44.
[33] M. Zasloff, Nature 415 (2002) 389–395.
[34] Y.J. Gordon, L.C. Huang, E.G. Romanowski, K.A. Yates, R.J. Proske, A.M. McDermott,
Curr. Eye Res. 30 (2005) 385–394.
[35] D. Avrahami, Y. Shai, Biochemistry 42 (2003) 14946–14956.
[36] K. Lohner, S.E. Blondelle, Comb. Chem. High Throughput Screen. 8 (2005) 241–256.
[37] B. Bechinger, K. Lohner, Biochim. Biophys. Acta 1758 (2006) 1529–1539.
[38] Z. Oren, Y. Shai, Novel Antimicrob. Agents 14 (2001) 184–204.
[39] K. Matsuzaki, Molecular mechanisms of membrane perturbation by antimicrobial peptides,
in: K. Lohner, (Ed.), Development of Novel Antimicrobial Agents: Emerging Strategies,
Horizon Scientific Press, Wymondham, Norfolk, UK, 2001, pp. 167–181.
Liposome-Based Biomembrane Mimetic Systems 133